p. 1083−1091
2536-9806
Vol.86/No.June
p. 1093−1098
2536-9806
Vol.86/No.June
p. 1099−1099
2536-9806
Vol.86/No.June
p. 1111−1117
2536-9806
Vol.86/No.June
p. 1119−1128
2536-9806
Vol.86/No.June
p. 1129−1138
2536-9806
Vol.86/No.June
p. 1139−1148
2536-9806
Vol.86/No.June
p. 1149−1158
2536-9806
Vol.86/No.June
p. 1159−1163
2536-9806
Vol.86/No.June
_4000gs, leading to underestimation of ABW (actual birth weight).Conclusion: We conclude that to improve the accuracy of fetal weight estimation, sonographic formulae that are based on 3 or 4 fetal biometric indices should be preferred.]]>
p. 1165−1170
2536-9806
Vol.86/No.June
p. 1171−1177
2536-9806
Vol.86/No.June
p. 1179−1183
2536-9806
Vol.86/No.June
p. 1185−1185
2536-9806
Vol.86/No.June
p. 1193−1202
2536-9806
Vol.86/No.June
p. 1203−1208
2536-9806
Vol.86/No.June
p. 1209−1212
2536-9806
Vol.86/No.June
p. 1213−1219
2536-9806
Vol.86/No.June
p. 1221−1225
2536-9806
Vol.86/No.June
p. 1227−1230
2536-9806
Vol.86/No.June
p. 1231−1241
2536-9806
Vol.86/No.June
p. 1243−1252
2536-9806
Vol.86/No.June
p. 1253−1261
2536-9806
Vol.86/No.June
p. 1263−1270
2536-9806
Vol.86/No.June
p. 1271−1279
2536-9806
Vol.86/No.June
p. 1281−1286
2536-9806
Vol.86/No.June
p. 1287−1294
2536-9806
Vol.86/No.June
150 pounds per month (OR=4.5) and students who liver away from their families (OR=3.7).Conclusion and Recommendations: Smoking is prevalent among Assiut University Students. An integrated smoking prevention program in the university students was recom-mended.]]>
p. 1295−1301
2536-9806
Vol.86/No.June
p. 1303−1309
2536-9806
Vol.86/No.June
p. 1311−1321
2536-9806
Vol.86/No.June
p. 1323−1329
2536-9806
Vol.86/No.June
p. 1331−1337
2536-9806
Vol.86/No.June
p. 1339−1344
2536-9806
Vol.86/No.June
p. 1345−1355
2536-9806
Vol.86/No.June
p. 1357−1366
2536-9806
Vol.86/No.June
p. 1367−1376
2536-9806
Vol.86/No.June
p. 1377−1382
2536-9806
Vol.86/No.June
p. 1383−1389
2536-9806
Vol.86/No.June
50%), mod-erate (EF=40-50%) and severe (EF <40%) and compared for clinical, angiographic and procedural variables.Results: On statistical analysis between studied groups, the principal finding of this study was that depressed LV function in patients with first acute anterior MI was associated with longer time to door (r=0.560, p=<0.001) and door to balloon (r=0.378, p=<0.001) times, higher CKMB level (r=0.565, p=<0.001), renal impairment defined as creatinine clearance <60mL/min (p=0.013), peripheral vascular disease (p=0.013), low TIMI flow grade before and after angioplasty (r=0.347, p=<0.001), low myocardial blush grade (r=0.347, p=<0.001). Regarding in-hospital mortality and major cardi-ovascular events defined as recurrent myocardial infarction, repeat coronary revascularization of the target lesion, and heart failure, was higher in Group III.Conclusion: Degree of LV dysfunction following first acute anterior MI can be identified by clinical and angiographic variables that are readily available at the time of initial assessment. The principal finding of this study is that abnormal LV systolic function after first acute anterior MI can be predicted by longer door to balloon time and larger infarction size as assessed by CKMB levels. Renal impairment, peripheral vascular disease, multi-vessel disease and low TIMI flow grade before and after angioplasty are associated with depressed LV function in patients with first acute anterior MI.]]>
p. 1391−1398
2536-9806
Vol.86/No.June
p. 1399−1406
2536-9806
Vol.86/No.June
p. 1407−1413
2536-9806
Vol.86/No.June
p. 1415−1419
2536-9806
Vol.86/No.June
p. 1421−1429
2536-9806
Vol.86/No.June
p. 1431−1445
2536-9806
Vol.86/No.June
p. 1447−1456
2536-9806
Vol.86/No.June
p. 1457−1463
2536-9806
Vol.86/No.June
p. 1465−1473
2536-9806
Vol.86/No.June
p. 1475−1477
2536-9806
Vol.86/No.June
p. 1479−1484
2536-9806
Vol.86/No.June
p. 1505−1511
2536-9806
Vol.86/No.June
p. 1513−1522
2536-9806
Vol.86/No.June
p. 1485−1495
2536-9806
Vol.86/No.June
p. 1497−1503
2536-9806
Vol.86/No.June
p. 1523−1528
2536-9806
Vol.86/No.June
p. 1529−1531
2536-9806
Vol.86/No.June
p. 1533−1536
2536-9806
Vol.86/No.June
p. 1537−1540
2536-9806
Vol.86/No.June
p. 1541−1544
2536-9806
Vol.86/No.June
p. 1545−1554
2536-9806
Vol.86/No.June
p. 1555−1563
2536-9806
Vol.86/No.June
5%).Conclusion: Our study demonstrated the decrease in the serum level of two markers (IL-6 and IL-10) in AML patients after induction chemotherapy, suggesting that assessment of their levels may be used as a prognostic markers and beneficial in the evaluation of the therapy making them highly applicable to routine clinical laboratories.]]>
p. 1565−1572
2536-9806
Vol.86/No.June
p. 1573−1576
2536-9806
Vol.86/No.June
p. 1577−1587
2536-9806
Vol.86/No.June
p. 1599−1606
2536-9806
Vol.86/No.June
p. 1607−1611
2536-9806
Vol.86/No.June
p. 1613−1620
2536-9806
Vol.86/No.June
p. 1621−1625
2536-9806
Vol.86/No.June
p. 1627−1633
2536-9806
Vol.86/No.June
p. 1635−1648
2536-9806
Vol.86/No.June
p. 1649−1656
2536-9806
Vol.86/No.June
p. 1657−1661
2536-9806
Vol.86/No.June
p. 1663−1670
2536-9806
Vol.86/No.June
p. 1671−1678
2536-9806
Vol.86/No.June
p. 1679−1681
2536-9806
Vol.86/No.June
p. 1683−1692
2536-9806
Vol.86/No.June
p. 1693−1697
2536-9806
Vol.86/No.June
p. 1699−1706
2536-9806
Vol.86/No.June
p. 1707−1712
2536-9806
Vol.86/No.June
p. 1713−1718
2536-9806
Vol.86/No.June
p. 1719−1725
2536-9806
Vol.86/No.June
p. 1727−1735
2536-9806
Vol.86/No.June
p. 1737−1742
2536-9806
Vol.86/No.June
p. 1743−1750
2536-9806
Vol.86/No.June
p. 1751−1758
2536-9806
Vol.86/No.June
p. 1759−1766
2536-9806
Vol.86/No.June
p. 1767−1775
2536-9806
Vol.86/No.June
p. 1777−1791
2536-9806
Vol.86/No.June
p. 1793−1799
2536-9806
Vol.86/No.June
p. 1801−1806
2536-9806
Vol.86/No.June
p. 1807−1810
2536-9806
Vol.86/No.June
p. 1811−1816
2536-9806
Vol.86/No.June
p. 1817−1823
2536-9806
Vol.86/No.June
p. 1825−1825
2536-9806
Vol.86/No.June
p. 1837−1845
2536-9806
Vol.86/No.June
p. 1847−1853
2536-9806
Vol.86/No.June
p. 1855−1866
2536-9806
Vol.86/No.June
p. 1867−1874
2536-9806
Vol.86/No.June
p. 1875−1881
2536-9806
Vol.86/No.June
p. 1883−1889
2536-9806
Vol.86/No.June
p. 1891−1899
2536-9806
Vol.86/No.June
p. 1901−1907
2536-9806
Vol.86/No.June
p. 1909−1915
2536-9806
Vol.86/No.June
p. 1917−1925
2536-9806
Vol.86/No.June
p. 1927−1932
2536-9806
Vol.86/No.June
p. 1933−1938
2536-9806
Vol.86/No.June
p. 1939−1946
2536-9806
Vol.86/No.June
p. 1947−1953
2536-9806
Vol.86/No.June
p. 1955−1962
2536-9806
Vol.86/No.June
p. 1971−1974
2536-9806
Vol.86/No.June
p. 1975−1982
2536-9806
Vol.86/No.June
p. 1983−1994
2536-9806
Vol.86/No.June
p. 1995−2000
2536-9806
Vol.86/No.June
p. 2001−2010
2536-9806
Vol.86/No.June
p. 2011−2017
2536-9806
Vol.86/No.June
p. 2019−2028
2536-9806
Vol.86/No.June
p. 2029−2034
2536-9806
Vol.86/No.June
p. 2035−2043
2536-9806
Vol.86/No.June
0.05). A total of 17 hypoglycemia events (11 categorized as serious) and one hyperglycemic event were recorded.Conclusion: Under real-world clinical practice insulin glargine 100U/ml as add-on to OADs, or in combination with prandial insulin, demonstrated a good efficacy and safety profile in people with T2DM uncontrolled previous on OAD therapy.]]>
p. 2045−2050
2536-9806
Vol.86/No.June
0.05). There was a significant positive correlation between choroidal thickness and average RNFL thickness (r=0.804, p-value <0.001).Conclusion: Lack of a significant difference in subfoveal choroidal thickness among normal eyes, eyes with POAG and eyes with PACG. A significant positive correlation existed between choroidal thickness and average RNFL thickness.]]>
p. 2051−2058
2536-9806
Vol.86/No.June
p. 2059−2064
2536-9806
Vol.86/No.June
10.Conclusion: MELD score has significant positive corre-lation with TNM tumour stage in HCC cases. CHC patients with MELD score >10 have SSLR for HCC presence of 4.57 and are in need for closer follow-up.]]>
p. 2073−2078
2536-9806
Vol.86/No.June
p. 2079−2090
2536-9806
Vol.86/No.June
p. 2091−2099
2536-9806
Vol.86/No.June
p. 2101−2108
2536-9806
Vol.86/No.June
p. 2109−2113
2536-9806
Vol.86/No.June
p. 2115−2121
2536-9806
Vol.86/No.June
p. 2123−2126
2536-9806
Vol.86/No.June
p. 2127−2139
2536-9806
Vol.86/No.June